| RS1057520292 |
IKBKG
|
Health Risk |
Likely pathogenic |
— |
| RS1057520293 |
IL2RG
|
Health Risk |
Likely pathogenic |
— |
| RS1057520297 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, Wieacker-Wolff syndrome |
| RS1057520298 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, ZC4H2-related X-linked intellectual disability |
| RS1057520299 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, Wieacker-Wolff syndrome |
| RS1057520300 |
SLC12A1
|
Health Risk |
Pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS1057520301 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS1057520302 |
SLC12A1
|
Health Risk |
Pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS1057520303 |
SLC12A1
|
Health Risk |
Pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS1057520304 |
SLC12A1
|
Health Risk |
Pathogenic |
Bartter disease type 1, Inborn genetic diseases |
| RS1057520306 |
TUBB8
|
Health Risk |
Pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1057520307 |
TUBB8
|
Health Risk |
Pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1057520312 |
MFSD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1057520316 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1057520319 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1057520326 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS1057520329 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1057520333 |
NDP
|
Health Risk |
Likely pathogenic |
— |
| RS1057520338 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS1057520339 |
NSD1
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Sotos syndrome |
| RS1057520344 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1057520345 |
PIGN
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1057520347 |
PMS2
|
Health Risk |
Pathogenic |
Lynch syndrome 4, Lynch syndrome 4 |
| RS1057520352 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Lethal congenital glycogen storage disease of heart |
| RS1057520353 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Lethal congenital glycogen storage disease of heart |
| RS1057520361 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1057520366 |
SERPING1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS1057520367 |
SETX
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1057520369 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1057520375 |
SMC1A
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1057520377 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1057520379 |
STK11
|
Health Risk |
Likely pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520382 |
TANGO2
|
Health Risk |
Likely pathogenic |
— |
| RS1057520384 |
TH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1057520391 |
TUBB2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TUBB2B-related disorder |
| RS1057520398 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1057520406 |
NRXN1
|
Health Risk |
Likely pathogenic |
— |
| RS1057520412 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520413 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1057520417 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 2A, Cardiomyopathy |
| RS1057520433 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520444 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1057520447 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1057520468 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1057520476 |
GABRG2
|
Health Risk |
Likely pathogenic |
— |
| RS1057520477 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS1057520486 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1057520487 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1057520498 |
GABRG2
|
Health Risk |
Pathogenic |
Febrile seizures, familial |
| RS1057520504 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1057520507 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1057520508 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1057520512 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1057520515 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS1057520517 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1057520520 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS1057520525 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS1057520528 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS1057520529 |
FOXP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, FOXP3-related disorder |
| RS1057520530 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057520531 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 3, Brugada syndrome 1 |
| RS1057520533 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1057520535 |
EXT1
|
Health Risk |
Pathogenic |
— |
| RS1057520536 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS1057520537 |
MOGS
|
Health Risk |
Pathogenic |
— |
| RS1057520538 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked syndromic |
| RS1057520539 |
KITLG
|
Health Risk |
Pathogenic |
Hyperpigmentation with or without hypopigmentation, familial progressive |
| RS1057520540 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS1057520542 |
AICDA
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 2, AICDA-related disorder |
| RS1057520543 |
RSPH9
|
Health Risk |
Pathogenic |
— |
| RS1057520544 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS1057520545 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1057520548 |
RS1
|
Health Risk |
Pathogenic |
— |
| RS1057520549 |
CNTNAP2
|
Health Risk |
Pathogenic |
— |
| RS1057520551 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1057520552 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS1057520556 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS1057520557 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Familial hypocalciuric hypercalcemia |
| RS1057520558 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1057520559 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS1057520561 |
TECTA
|
Health Risk |
Pathogenic |
— |
| RS1057520562 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1057520565 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1057520566 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1057520567 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1057520568 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057520569 |
IRF6
|
Health Risk |
Pathogenic |
— |
| RS1057520571 |
CLN6
|
Health Risk |
Likely pathogenic |
— |
| RS1057520573 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1057520574 |
TUBA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1057520575 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1057520576 |
PDGFB
|
Health Risk |
Pathogenic |
— |
| RS1057520577 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS1057520578 |
BTK
|
Health Risk |
Likely pathogenic |
Inherited Immunodeficiency Diseases, Inherited Immunodeficiency Diseases |
| RS1057520579 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, Emery-Dreifuss muscular dystrophy |
| RS1057520580 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1057520581 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1057520582 |
PHEX
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1057520583 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS1057520584 |
MEF2C
|
Health Risk |
Pathogenic |
— |